Abstract
There is controversy of whether prophylaxis treatment or a ‘‘screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.